DK1136081T3 - Sammensætninger med forhalet frigivelse til parenteral indgivelse af makrolider - Google Patents
Sammensætninger med forhalet frigivelse til parenteral indgivelse af makroliderInfo
- Publication number
- DK1136081T3 DK1136081T3 DK01302438T DK01302438T DK1136081T3 DK 1136081 T3 DK1136081 T3 DK 1136081T3 DK 01302438 T DK01302438 T DK 01302438T DK 01302438 T DK01302438 T DK 01302438T DK 1136081 T3 DK1136081 T3 DK 1136081T3
- Authority
- DK
- Denmark
- Prior art keywords
- macrolides
- delayed
- parenteral administration
- release compositions
- compositions
- Prior art date
Links
- 230000003111 delayed effect Effects 0.000 title 1
- 239000003120 macrolide antibiotic agent Substances 0.000 title 1
- 229940041033 macrolides Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000007911 parenteral administration Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19069900P | 2000-03-20 | 2000-03-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1136081T3 true DK1136081T3 (da) | 2005-02-21 |
Family
ID=22702398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01302438T DK1136081T3 (da) | 2000-03-20 | 2001-03-16 | Sammensætninger med forhalet frigivelse til parenteral indgivelse af makrolider |
Country Status (15)
Country | Link |
---|---|
US (1) | US6552002B2 (da) |
EP (1) | EP1136081B1 (da) |
JP (1) | JP4817515B2 (da) |
AR (1) | AR027681A1 (da) |
AT (1) | ATE286406T1 (da) |
AU (1) | AU781682B2 (da) |
BR (1) | BR0101090A (da) |
CA (1) | CA2341281C (da) |
DE (1) | DE60108189T2 (da) |
DK (1) | DK1136081T3 (da) |
ES (1) | ES2233566T3 (da) |
MX (1) | MXPA01002861A (da) |
NZ (1) | NZ510538A (da) |
PT (1) | PT1136081E (da) |
SI (1) | SI1136081T1 (da) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4850390B2 (ja) * | 2001-10-19 | 2012-01-11 | アイデックス ラボラトリーズ インコーポレイテッド | 薬理学的に活性な化合物の制御送達のための注射用組成物 |
UY27412A1 (es) * | 2002-08-12 | 2003-06-30 | Carlson Internat Inc | Un nuevo producto para el combate de garrapatas y el proceso para la prepaacinn. |
US7906128B2 (en) * | 2002-10-21 | 2011-03-15 | Wyeth Llc | Use of neuronal sodium channel antagonists for the control of ectoparasites in homeothermic animals |
US7396819B2 (en) * | 2003-08-08 | 2008-07-08 | Virbac Corporation | Anthelmintic formulations |
US7582612B2 (en) * | 2004-03-12 | 2009-09-01 | Hartz Mountain Corporation | Multi-action anthelmintic formulations |
GB0425919D0 (en) * | 2004-11-25 | 2004-12-29 | Prosidion Ltd | Indole-2-carboxylic acid amides |
EP2351713B1 (en) | 2008-09-09 | 2013-08-14 | Asahi Glass Company, Limited | Air-cool intensifying apparatus for glass plate, and air-cool intensifying method |
UY33282A (es) * | 2010-03-25 | 2011-09-30 | Novartis Ag | Composiciones endoparasiticidas |
KR101494594B1 (ko) * | 2011-08-30 | 2015-02-23 | 주식회사 종근당 | 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
US9616044B2 (en) | 2012-03-13 | 2017-04-11 | Bayer New Zealand Ltd | Long acting compositions |
JP5717034B2 (ja) * | 2012-08-27 | 2015-05-13 | 丸和バイオケミカル株式会社 | マクロライド系化合物を含有する土壌線虫防除用薬剤 |
KR101586791B1 (ko) | 2012-12-28 | 2016-01-19 | 주식회사 종근당 | GnRH 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
US10220093B2 (en) | 2013-02-28 | 2019-03-05 | Mira Pharma Corporation | Long-acting semi-solid lipid formulations |
CN105120839B (zh) | 2013-02-28 | 2020-07-28 | 湖州惠中济世生物科技有限公司 | 可注射长效局麻药半固体制剂及其组成成分 |
ITUB20153652A1 (it) | 2015-09-16 | 2017-03-16 | Fatro Spa | Microsfere contenenti lattoni macrociclici antielminitici |
GB2552952B (en) * | 2016-08-12 | 2020-03-04 | Norbrook Lab Ltd | Moxidectin topical liquid formulations |
US11426418B2 (en) | 2017-12-06 | 2022-08-30 | Mira Pharma Corporation | Injectable long-acting semi-solid gel formulations |
US10561606B2 (en) | 2017-12-06 | 2020-02-18 | Mira Pharma Corporation | Injectable long-acting local anesthetic semi-solid gel formulations |
CA3141337A1 (en) * | 2019-05-24 | 2020-12-03 | Piedmont Animal Health Inc. | Long-acting injectable formulations and use thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4389397A (en) * | 1980-08-04 | 1983-06-21 | Merck & Co., Inc. | Solubilization of ivermectin in water |
JPS57171919A (en) * | 1981-04-17 | 1982-10-22 | Nippon Kayaku Co Ltd | Orally administering composition for veterinary purposes |
EP0179583A1 (en) * | 1984-10-04 | 1986-04-30 | Merck & Co. Inc. | A system for enhancing the water dissolution rate and solubility of poorly soluble drugs |
AU713580B2 (en) | 1995-09-25 | 1999-12-02 | Merial Ltd | Anthelmintic macrocyclic lactone compositions |
DE19613972A1 (de) * | 1996-04-09 | 1997-10-16 | Bayer Ag | Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl |
AU728221B2 (en) * | 1996-06-05 | 2001-01-04 | Ashmont Holdings Limited | Injectable compositions |
DE19638045A1 (de) | 1996-09-18 | 1998-03-19 | Bayer Ag | Injektionsformulierungen von Avermectinen und Milbemycinen |
CA2211949A1 (en) * | 1997-07-21 | 1999-01-29 | David Farley Johnson | Nonaqueous compositions for parenteral administration |
-
2001
- 2001-03-08 AU AU26415/01A patent/AU781682B2/en not_active Expired
- 2001-03-13 JP JP2001070267A patent/JP4817515B2/ja not_active Expired - Fee Related
- 2001-03-14 NZ NZ510538A patent/NZ510538A/en not_active IP Right Cessation
- 2001-03-15 US US09/809,525 patent/US6552002B2/en not_active Expired - Lifetime
- 2001-03-16 DE DE60108189T patent/DE60108189T2/de not_active Expired - Lifetime
- 2001-03-16 CA CA2341281A patent/CA2341281C/en not_active Expired - Lifetime
- 2001-03-16 SI SI200130280T patent/SI1136081T1/xx unknown
- 2001-03-16 DK DK01302438T patent/DK1136081T3/da active
- 2001-03-16 AT AT01302438T patent/ATE286406T1/de active
- 2001-03-16 PT PT01302438T patent/PT1136081E/pt unknown
- 2001-03-16 EP EP01302438A patent/EP1136081B1/en not_active Expired - Lifetime
- 2001-03-16 ES ES01302438T patent/ES2233566T3/es not_active Expired - Lifetime
- 2001-03-19 MX MXPA01002861A patent/MXPA01002861A/es active IP Right Grant
- 2001-03-19 AR ARP010101275A patent/AR027681A1/es not_active Application Discontinuation
- 2001-03-19 BR BR0101090-5A patent/BR0101090A/pt active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CA2341281C (en) | 2010-11-02 |
AU2641501A (en) | 2001-09-27 |
ATE286406T1 (de) | 2005-01-15 |
DE60108189T2 (de) | 2005-06-02 |
CA2341281A1 (en) | 2001-09-20 |
EP1136081B1 (en) | 2005-01-05 |
AU781682B2 (en) | 2005-06-09 |
JP4817515B2 (ja) | 2011-11-16 |
SI1136081T1 (en) | 2005-04-30 |
NZ510538A (en) | 2002-06-28 |
AR027681A1 (es) | 2003-04-09 |
EP1136081A1 (en) | 2001-09-26 |
DE60108189D1 (de) | 2005-02-10 |
MXPA01002861A (es) | 2002-06-04 |
PT1136081E (pt) | 2005-03-31 |
ES2233566T3 (es) | 2005-06-16 |
US20020004486A1 (en) | 2002-01-10 |
JP2001261558A (ja) | 2001-09-26 |
US6552002B2 (en) | 2003-04-22 |
BR0101090A (pt) | 2001-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1136081T3 (da) | Sammensætninger med forhalet frigivelse til parenteral indgivelse af makrolider | |
DK1421939T3 (da) | Præparat med opretholdt frigivelse af en makrolidforbindelse såsom tacrolimus | |
DK1296656T3 (da) | Fremgangsmåde til fremstilling af et præparat | |
DK2158905T3 (da) | Sammensætning til transdermal administration af fentanyl | |
DK1326585T3 (da) | Fremgangsmåde til fremstilling af pulverformuleringer | |
DK1296935T3 (da) | Fremgangsmåde til fremstilling af substituerede octanoylamider | |
DK1309327T3 (da) | Farmaceutiske sammensætninger af østrogene midler | |
DK1277722T3 (da) | Fremgangsmåde til fremstilling af methanol | |
DK1253153T3 (da) | Fremgangsmåde til fremstilling af 4"-substituerede-9-deoxo-9a-aza-9a-homoerythromycin-A-derivater | |
DK1341531T3 (da) | Lactamforbindelser til inhibering af beta-amyloidpeptidfrigivelse eller - syntese | |
DK1132570T3 (da) | Sammensætninger til syrebehandling af borebrönde | |
DK1181036T3 (da) | Farmaceutiske sammensætninger af erythropoietin | |
IS6508A (is) | Lyfjasamsetningar af glycogen fosfórýlasa lötum | |
DK1309545T3 (da) | Fremgangsmåde til fremstilling af alkylarylsulfonater | |
DK1142477T3 (da) | Sammensætninger med reguleret frigivelse | |
DK1349580T3 (da) | Fremgangsmåde til forbedring af stabiliteten af en farmaceutisk sammensætning | |
DK1147075T3 (da) | Fremgangsmåde til fremstilling af L-phenylephrinhydrochlorid | |
DK1667967T3 (da) | Fremgangsmåde til fremstilling af 2-oxo-1-pyrrolidin-derivater | |
DK1407037T3 (da) | Fremgangsmåde til fremstilling af tagatose | |
DK1272489T3 (da) | Fremgangsmåde til præparation af cabergolins krystallinske form I | |
DK1345939T3 (da) | Fremgangsmåde til fremstilling af sulfonamidsubstituerede imidazotriazinoner | |
IS2349B (is) | Lyfjafræðileg drónedarón samsetning til gjafar utan meltingarvegar | |
DK1456229T3 (da) | Fremgangsmåe til fremstilling af echinocandin-derivater | |
DK1326836T3 (da) | Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin | |
DK1158963T3 (da) | Sammensætninger af betahistin med kontrolleret frigivelse |